News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi Adds GIANT BIOGENE's TP to HKD93.7 w/ Higher Earnings Forecasts
Citi has released a report revealing that GIANT BIOGENE (02367.HK) participated in its 2025 China Elite Corporate Day held in Shenzhen yesterday (14th).Seeing that GIANT BIOGENE...
Reset
Send
The window will close in 5 seconds
<Research>Citi Adds GIANT BIOGENE's TP to HKD93.7 w/ Higher Earnings Forecasts
Close
Recommend
5
Positive
7
Negative
4
 
SHORT SELL
 
STOCK INFO

Citi has released a report revealing that GIANT BIOGENE (02367.HK)  +0.350 (+0.414%)    Short selling $48.95M; Ratio 15.374%   participated in its 2025 China Elite Corporate Day held in Shenzhen yesterday (14th).

Seeing that GIANT BIOGENE's "618" promotion got off to a strong start on Tmall with a higher ranking, Citi expected growth momentum to come from new customers (making up 60-70% of the customer base) and a new product portfolio, where hero product Collagen Stick upgrade drove a 20% increase in ticket size and the sales contribution of Focus Cream climbed from the low- to mid-single digit to the mid- to high-single digit.

Management is currently maintaining its 2025 results guidance and will reassess after the final results of the prolonged promotion until late June.

Citi raised its 2025-27 earnings forecasts for GIANT BIOGENE by 5-18% to reflect the upward revision in revenue forecasts. It also lifted its target price from HKD78.1 to HKD93.7 and kept the Buy rating unchanged.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-16 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.